Use of hormonal contraceptives and risk of HIV-1 transmission

The Lancet Infectious Diseases

Volumn 12, Issue 7, 2012, Pages 508-509

  van Leeuwen, Roelof W ^a   de Vries, Frank ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; DISEASE TRANSMISSION; FOLLOW UP; HIV TEST; HORMONAL CONTRACEPTION; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; LETTER; LOWEST INCOME GROUP; PRIORITY JOURNAL; PROBABILITY; SELF REPORT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NOTE;

ORAL CONTRACEPTIVE AGENT;

CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE;

EID: 84862734568     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70113-5     Document Type: Letter

References (3)

1. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012, 12:19-26.
2. Boily M-C, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009, 9:118-129.
3. Savitz D Interpreting epidemiological evidence: strategies for study design and analysis 2003, Oxford University Press, Oxford.